✦ LIBER ✦

Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas

✍ Scribed by Gregory Y. Lauwers; Gregory V. Scott; Martin S. Karpeh

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 779 KB
Volume: 75
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19950501)75:9<2209::aid-cncr2820750904>3.0.co;2-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunohistochemical evidence of aberrant

Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia

✍ Gregory Y. Lauwers; Gregory V. Scott; James Hendricks 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

## Background: Bcl-2 protein encoded by the proto-oncogene bcl-2 confers to the cell a survival advantage by inhibiting apoptosis. its aberrant expression has been reported in lymphomas and lung carcinoma. to determine if bcl-2 plays a role in the gastric carcinogenic sequence, the authors studied

Expression of cyclooxygenase-2 protein i

Expression of cyclooxygenase-2 protein in gastric adenocarcinoma

✍ Uefuji, Kazuhilo; Ichikura, Takashi; Mochizuki, Hidetaka; Shinomiya, Nariyoshi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 773 KB

Background and Objectives: Epidemiological studies have suggested that the regular use of nonsteroidal antiinflammatory drugs, which inhibit cyclooxygenase (COX), reduces the risk of colon cancer. The inducible COX-2 isoform has been reported to be upregulated in colorectal carcinomas and may play a

Expression of bcl-2, bax, and bcl-XL pro

Expression of bcl-2, bax, and bcl-XL proteins in azoxymethane-induced rat colonic adenocarcinomas

✍ Yoshinobu Hirose; Naoki Yoshimi; Masumi Suzui; Kunihiro Kawabata; Takuji Tanaka; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB 👁 2 views

Using western blotting and immunochemical analysis, we investigated alterations in the expression of the apoptosis-related proteins bcl-2, bax, and bcl-X in colonic adenocarcinomas induced by subcutaneous injection of azoxymethane (AOM) (15 mg/kg body weight weekly for 2 wk) into male Sprague-Dawley

Clinicopathologic evaluation of immunohi

Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas

✍ Yoshihide Shino; Akihiko Watanabe; Yukishige Yamada; Masahiro Tanase; Takashi Ya 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 878 KB

Expression of the Apoptosis suppressing

Expression of the Apoptosis suppressing protein bcl-2 in prostatic adenocarcinoma is related to tumor malignancy

✍ Lipponen, P.; Vesalainen, S. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 2 views

## Background: The expression of bcl-2 protein has been related to histopathological features and prognosis in several epithelial tumors. in prostatic adenocarcinoma the prognostic significance of bcl-2 expression is mainly unexplored. ## Methods: The expression of bcl-2 protein was assessed in 2

Bcl-2: Bax and Bcl-2: Bcl-x ratios by im

Bcl-2: Bax and Bcl-2: Bcl-x ratios by image cytometric quantitation of immunohistochemical expression in ovarian carcinoma: correlation with prognosis

✍ Christina M. Lohmann; Aimee A. League; W. Scott Clark; Diane Lawson; Patricia B. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB 👁 2 views

Bcl-2 is a proto-oncogene which is involved in prolonging cell survival by inhibiting programmed cell death. Bax and bcl-x are members of the bcl-2 family; when overexpressed, they can counteract the ability of bcl-2 to inhibit apoptosis. This suggests a model in which the ratios of bcl-2 to bax and